INM vs BIOA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 05, 2026

INM

48.0
AI Score
VS
INM Wins

BIOA

39.3
AI Score

Investment Advisor Scores

INM

48score
Recommendation
HOLD

BIOA

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric INM BIOA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -26.2% 1.6% BIOA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 48.0/100 39.3/100 INM
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY INM

Relative Price Performance (Last 90 Days)

INM 1M: +0.0% · 3M: -20.4% BIOA 1M: -32.1% · 3M: -73.6%

Current Technical Phase

INM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.9%), weak momentum, RSI 43

RSI (14): 43.2 · Price: $1.33

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -37.8%), weak momentum, RSI 24

RSI (14): 23.6 · Price: $6.45

Fundamentals Snapshot

Metric INM BIOA
Market Cap — —
Forward P/E 0.0 -2.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.3% 0.0%
Gross Margin 0.3% -7.5%
Operating Margin 0.0% -12.0%
EPS -2.82 -2.29
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, INM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.